SCHEMBL25712091

SCHEMBL25712091

CC(=O)[C@@H](N)CC(=O)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ SLC7A5 Q01650 1/20 0.36
▸ GRIK1 P39086 5/20 0.35
▸ PTGS1 P23219 1/20 0.33
▸ SLC7A11 Q9UPY5 1/20 0.33
▸ GRIA2 P42262 2/20 0.32
▸ GRIA4 P48058 2/20 0.32
▸ GRIK3 Q13003 2/20 0.32
▸ GRIK5 Q16478 2/20 0.32
▸ GRIK2 Q13002 2/20 0.32
▸ GRIA1 P42261 1/20 0.32
▸ SLC1A3 P43003 2/20 0.32
▸ SLC1A2 P43004 2/20 0.32
▸ SLC1A1 P43005 1/20 0.32
▸ ENPEP Q07075 2/20 0.31
▸ GABRP O00591 2/20 0.31
▸ GABRD O14764 2/20 0.31
▸ GABRA1 P14867 2/20 0.31
▸ GABRB1 P18505 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12368601 1.00 ALDH1A1 (0.36) ALDH1A1TDP1SLC7A5GRIK1PTGS1
SCHEMBL10212363 0.80 SLC7A5 (0.58) SLC7A5GRIK1PTGS1SLC7A11GRIA2
SCHEMBL21690060 0.80 SLC7A5 (0.58) SLC7A5GRIK1PTGS1SLC7A11GRIA2
SCHEMBL16018408 0.80 GABRP (0.36) ALDH1A1TDP1SLC7A5GRIK1PTGS1
SCHEMBL21577845 0.80 SLC7A5 (0.58) SLC7A5GRIK1PTGS1SLC7A11GRIA2
SCHEMBL21795118 0.78 GRIK1 (0.36) SLC7A5GRIK1PTGS1SLC7A11GRIA2
SCHEMBL18098558 0.78 SLC1A3 (0.32) ALDH1A1TDP1SLC7A5GRIK1SLC1A3
SCHEMBL13164039 0.77 — —
SCHEMBL11953210 0.76 SLC1A3 (0.38) SLC7A5GRIK1GRIA2GRIA4GRIK3
SCHEMBL25885239 0.76 SLC1A3 (0.38) SLC7A5GRIK1GRIA2GRIA4GRIK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11649215-B2 Compositions and methods for the treatment of oral infectious diseases CELLIX BIO PRIVATE LIMITED (IN) 2023-05-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11649215-B2 Compositions and methods for the treatment of oral infectious diseases SI, HBG1, HBG2 ALDH1A1 3560/4885TDP1 4190/4885SLC7A5 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback